Comvita Limited — Director's Dealing 2022

Mar 1, 2022

==> picture [87 x 25] intentionally omitted <==

Ongoing Disclosure Notice

Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013

==> picture [450 x 624] intentionally omitted <==

----- Start of picture text ----- To NZX Limited; andName of listed issuer: Comvita LimitedDate this disclosure made: 02-Mar-22Date of last disclosure: 26-Jun-20Director or senior manager giving disclosureFull name(s): Brett Donald HewlettName of listed issuer: Comvita LimitedName of related body corporate (if applicable): n/aPosition held in listed issuer: Company ChairSummary of acquisition or disposal of relevant interest (excluding specified derivatives)Class of affected quoted financial products: Ordinary SharesNature of the affected relevant interest(s): Hewlett Investment Fund Trust - registeredholderFor that relevant interest-Number held in class before acquisition or disposal: Brett Donald Hewlett - 65,290 quoted ordinarysharesHewlett Investment Fund Trust - 332,636 quotedordinary sharesNumber held in class after acquisition or disposal: Brett Donald Hewlett - 65,290 quoted ordinarysharesHewlett Investment Fund Trust - 335,636 quotedordinary sharesCurrent registered holder(s): Hewlett Investment Fund Trust - Brett DonaldHewlett, Rhonda Hewlett and YRW Trustees2005 LimitedRegistered holder(s) once transfers are registered: Same as current registered holdersDetails of transactions giving rise to acquisition or disposalTotal number of transactions to which notice relates: 1Details of transactions requiring disclosure-Date of transaction: 01-Mar-22Nature of transaction: Hewlett Investment Fund Trust - purchase of3,000 ordinary sharesName of any other party or parties to the transaction (if known): N/AThe consideration, expressed in New Zealand dollars, paid or received for the acquisition Total of NZD$10,200 being NZD$3.40 peror disposal. If the consideration was not in cash and cannot be readily by converted into a security.cash value, describe the consideration:Number of financial products to which the transaction related: 3,000If the issuer has a financial products trading policy that prohibits directors or seniormanagers from trading during any period without written clearance (a closed period)include the following details—Whether relevant interests were acquired or disposed of during a closed period: NoWhether prior written clearance was provided to allow the acquisition or disposal to N/Aproceed during the closed period:Date of the prior written clearance (if any): N/ACertificationI certify that, to the best of my knowledge and belief, the information contained in thisdisclosure is correct and that I am duly authorised to make this disclosure by all persons forwhom it is made.Signature of director or officer:Date of signature: 02-Mar-22----- End of picture text -----